Gunilla Källenius - Infectious Diseases

Author Information

Gunilla Källenius is a prominent researcher in the field of Infectious Diseases, affiliated with the Division of Infectious Diseases at the Department of Medicine Solna, Karolinska Institutet in Stockholm, Sweden. Her work primarily focuses on the study of Mycobacterium tuberculosis and related immunological responses, contributing significantly to the understanding and development of diagnostic tools and therapeutic interventions for tuberculosis.

Research Contributions

Gunilla Källenius has made substantial contributions to the field of tuberculosis research, particularly in the area of immune profiling and diagnostic development. Her research has explored diverse aspects of mycobacterial infections, including the performance of novel antibodies for lipoarabinomannan in developing diagnostic tests, immune response patterns in active and latent tuberculosis, and the role of mycobacterial glycolipids in immunomodulation. Her work also extends to understanding the morbid anatomy of patients with mycobacterial infections and developing mathematical models to identify contacts with recent and remote latent tuberculosis. These contributions have had a significant impact on advancing the knowledge and management of tuberculosis.

Aliases

Throughout her career, Gunilla Källenius has been referenced by several names, including G Källenius, G. Källenius, and Gunilla Källenius. These aliases reflect variations in the use of her full name in different publications and databases.

Publication and Citation Metrics

Metric	Value
Total Citation Count	7237
h-index	47
Total Paper Count	183

Publications:

Performance of novel antibodies for lipoarabinomannan to develop diagnostic tests for Mycobacterium tuberculosis

DOI: 10.1101/2022.04.12.488063

Year: 2022

High Dimensional Immune Profiling Reveals Different Response Patterns in Active and Latent Tuberculosis Following Stimulation With Mycobacterial Glycolipids

DOI: 10.3389/fimmu.2021.727300

Year: 2021

Stimulation with mycobacterial glycolipids and PPD reveals different innate immune response profiles in active and latent TB

DOI: 10.1101/2021.04.04.434373

Year: 2021

Morbid Anatomy of Patients with Mycobacterial Infections, a Cross Sectional Autopsy Study at a Tertiary Hospital in a High Disease Burden Setting

DOI: 10.2139/ssrn.3546085

Year: 2020

Stabilization of blood for long-term storage can affect antibody-based recognition of cell surface markers.

DOI: 10.1016/j.jim.2020.112792

Year: 2020

Editorial: Mycobacterial Glycolipids—Role in Immunomodulation and Targets for Vaccine Development

DOI: 10.3389/fimmu.2020.603900

Year: 2020

CD4+ T cell proliferative responses to PPD and CFP-10 associate with recent M. tuberculosis infection.

DOI: 10.1016/j.tube.2020.101959

Year: 2020

Lipoarabinomannan in Active and Passive Protection Against Tuberculosis

DOI: 10.3389/fimmu.2019.01968

Year: 2019

Biomarkers for tuberculosis: the case for lipoarabinomannan

DOI: 10.1183/23120541.00115-2018

Year: 2019

A new mathematical model to identify contacts with recent and remote latent tuberculosis

DOI: 10.1183/23120541.00078-2019

Year: 2019

When is Ultrasound Used?

What are the Legal and Ethical Considerations?

What Role Does Vaccination Play in Global Health?

What Are the Common Symptoms of Immunodeficiency Disorders?

How is Immunotherapy Used in Treating Infectious Diseases?

What are Some Examples of Structural Proteins in Infectious Diseases?

What are the Symptoms in Humans?

How Does Vaccine Hesitancy Impact Public Health?

Are There Alternatives to Antipyretics?

What are the Technological Advances in Genomic Sequencing?

Partnered Content Networks

Relevant Topics